Renal cystic disease in lithium treated patients assessment by MRI and renal ultrasound.

Renal cystic disease in lithium treated patients assessment by MRI and renal ultrasound. - Detecting renal cystic disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38734

Enrollment

Registered

2014-01-09

Start date

2014-03-25

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

microcysts small renal cysts

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusioncriteria (patients) - patients (m/f, age *18 years) with a bipolar disorder treated with lithium

Exclusion criteria

Exclusion criteria: - general contra-indications for participation in a trial: - inability to give informed consent - pregnancy - unstable psychiatric condition ;- Inability to undergo MRI. - standard contra-indications for MR ( in accordance with the hospital protocol), such as the presence of metallic fragments, clips or devices including implantable pacemakers and implantable cardioverter-defibrillators, extreme overweight, claustrophia

Design outcomes

Primary

Measure	Time frame
The prevalence and a semi-quantitative measurement of the number and size of microcysts in lithium treated patients.	—

Secondary

Measure	Time frame
Relation between MRI and ultrasound results * presence of microcysts * and clinical parameters (duration of lithium therapy, plasma lithium concentration, baseline plasma creatinine, sodium and potassium concentration and baseline urinary osmolality)	—

Countries

Netherlands

Outcome results